A pharma summer — how leaders unwind and recharge their teams in the warmer months
PharmaVoice
JUNE 30, 2023
Vacation is calling, but so are patients. Here's how the industry adjusts in the summer.
Fri.Jun 30, 2023
255 
5 Ways AI Pricing Offers Predictable Profitability
Drug Topics
JUNE 30, 2023
With high-deductible health plans on the rise, pharmacists need a cash pricing plan now. Artificial intelligence, or AI, could be the answer. Learn more about this innovative technology and how it could impact your bottom line.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pursuing a Career in Pharmacy: Empowering LGBTQIA+ Students through Advocacy and Diversity
Pharmacy Is Right For Me
JUNE 30, 2023
Join us as we explore the inspiring journey of Cayden Miller, a passionate pharmacy graduate from Southern Illinois University at Edwardsville School of Pharmacy. Cayden’s experience as a member of the LGBTQIA+ community has shaped his path in pharmacy, driving him to become an advocate for diversity, equity, and inclusion (DEI) within the profession.
Could a Cash-Based System Help Eliminate Health Care Barriers?
Drug Topics
JUNE 30, 2023
Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
CDC Announces Recommendation for RSV Vaccine in Older Adults
Pharmacy Times
JUNE 30, 2023
The new RSV vaccines are expected to be available in fall 2023.
NDA for Givinostat to Treat Duchenne Muscular Dystrophy Accepted by FDA
Drug Topics
JUNE 30, 2023
The acceptance comes 5 days after the agency approved delandistrogene moxeparvovec-rokl to treat ambulatory pediatric DMD patients aged 4 to 5 years.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Revised Guidance for Medicare Price Negotiation Released by CMS
Drug Topics
JUNE 30, 2023
The revised guidance includes clarified aspects of the negotiation process and additional opportunities for engagement during the process.
FDA Approves BioMartin’s Roctavian for Treatment of Severe Hemophilia A
Pharmacy Times
JUNE 30, 2023
Valoctocogene roxaparvovec-rvox (Roctavian; BioMarin) is a one-time gene therapy product administered as a single dose by intravenous infusion for hemophilia A.
Former Pfizer employee charged with insider trading, using advance information on Paxlovid trial
Fierce Pharma
JUNE 30, 2023
A former statistician at Pfizer and his associate have been charged (PDF) with insider trading, using advance inform | A former statistician at Pfizer and his associate have been charged with insider trading, using advance information to make more than $350,000 from stock purchases that they executed one day before the company made trial results public for COVID-19 blockbuster Paxlovid.
Why Independent Pharmacies Remain a Pillar for Access, Community Health
Pharmacy Times
JUNE 30, 2023
Independent pharmacies can provide more personalized care to individuals with behavioral health conditions or intellectual and developmental disabilities.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost
STAT
JUNE 30, 2023
Pat Furlong was sitting in her home office in Middletown, Ohio, last Thursday, refreshing a Food and Drug Administration web page ad nauseam, when the phone rang. She answered and burst into tears. The FDA had just approved the first gene therapy for Duchenne muscular dystrophy, her friend and the therapy’s architect, Jerry Mendell, told her.
Busting Common Medication Myths: Pharmacists Empowering Patients with Accurate Information
Pharmacy Times
JUNE 30, 2023
As one of the most trusted health care professionals, pharmacists play a vital role in debunking medication myths by providing patients with accurate information to make positive decisions regarding their health.
Health Canada approves Endo’s anti-seizure pills
Pharmaceutical Technology
JUNE 30, 2023
Health Canada has approved Endo International’s Xcopri as adjunctive therapy in the management of partial-onset seizures in adults with epilepsy.
Plant-Based Insulin May Be More Effective, Affordable Than Clinical Insulin for Patients With Diabetes
Pharmacy Times
JUNE 30, 2023
Plant-based insulin contains all 3 peptides that are found in insulin naturally produced by the body.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
UK pilot will seek digital dimension to dementia management
pharmaphorum
JUNE 30, 2023
UK pilot will seek digital dimension to dementia management Phil.
Patient-Reported Questionnaire Could Aid the Evaluation of Respiratory Syncytial Virus Symptoms
Pharmacy Times
JUNE 30, 2023
Findings suggest that psychometric tests used for The Respiratory Infection Intensity and Impact Questionnaire provide reliable, construct validity, and responsive evidence to detect onset symptoms of RSV.
Healthcare groups fear SCOTUS affirmative action ruling will harm diversity, health equity efforts
Fierce Healthcare
JUNE 30, 2023
The U.S. | The SCOTUS rulings Thursday will have far-reaching consequences for the healthcare industry and its collective efforts to address diversity in the workforce and health inequities among underrepresented groups.
Mild Hypercapnia Does Not Lead to Better Neurological Outcomes at 6 Months Compared to Normocapnia in Resuscitated Patients With Coma
Pharmacy Times
JUNE 30, 2023
Despite prior studies showing less brain injury biomarkers in patients with targeted mild hypercapnia, findings from a new trial suggest it does not improve neurological outcomes at 6 months.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Medicare details the structure of its new drug price negotiation program
STAT
JUNE 30, 2023
WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work , just two months before it’s set to start. Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final.
Testosterone-Replacement Therapy in Men With Hypogonadism Does Not Increase Risk of Cardiovascular Events
Pharmacy Times
JUNE 30, 2023
Until now, studies examining the relationship between testosterone and adverse cardiovascular events in men with hypogonadism were limited and inconsistent.
Neuro expands national retail footprint
Drug Store News
JUNE 30, 2023
With this latest retail expansion, Neuro Gum and Neuro Mints are now available in more than 10,000 retailers nationwide.
Overview of Current MM Treatment Landscape
Pharmacy Times
JUNE 30, 2023
Drs Haumschild, Anderson, and Hinojosa explore current MM treatment pathways.
Biomarker study raises hope of better depression therapies
pharmaphorum
JUNE 30, 2023
Biomarker study raises hope of better depression therapies Phil.
Galcanezumab-gnlm Demonstrates Clinically Meaningful Efficacy, Safety in 3 Months for Migraine
Pharmacy Times
JUNE 30, 2023
Galcanezumab-gnlm (Emgality; Eli Lilly and Company) did not demonstrate superiority to rimegepant orally disintegrating tablet (Nurtec ODT) on the percentage of individuals achieving a 50% or greater reduction in monthly migraine headache days.
In Depth Focus QA/QC Microbiology/RMM 2023
European Pharmaceutical Review
JUNE 30, 2023
A collaborative approach to advancing adoption of RMMs EPR ’s Caroline Peachey explores collaborative efforts to accelerate validation and adoption of rapid microbial methods across the pharmaceutical industry. The power of rapid methods for fungal ID By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety.
STAT+: Bright Health sells Medicare Advantage plans to Molina for $600 million
STAT
JUNE 30, 2023
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare. Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.
Low Dose Naltrexone and Hashimoto’s
The Thyroid Pharmacist
JUNE 30, 2023
Have you heard of low dose naltrexone, or LDN? Since the beginning of my Hashimoto’s journey, this medication has been on my radar – and in recent years, I have learned so much more about it. In 2015, I conducted a survey of over 2000 readers with Hashimoto’s , asking for the most helpful interventions in their health journeys. One reader wrote: “Low Dose Naltrexone changed my life for the better.
After affirmative action ruling, medical education leaders see silver lining in court endorsement of ‘holistic review’
STAT
JUNE 30, 2023
After having a day to read through the Supreme Court’s decision on affirmative action , some medical school and educational leaders are more hopeful that a path exists for them to diversify future classes and the health care workforce as they scramble to understand its impact on the next admissions cycle and the class of 2024. Several told STAT they saw the court’s ruling as explicitly endorsing the use of “holistic review,” a tool used increasingly by medical, dental
Walgreens to shutter 150 stores in U.S., 300 stores in U.K.
Drug Store News
JUNE 30, 2023
Following the recent elimination of more than 500 roles, Walgreens Boots Alliance is planning to close 300 locations in the U.K. and 150 in the United States.
STAT+: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
STAT
JUNE 30, 2023
In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences and Teva Pharmaceuticals of allegations that the companies struck an illegal deal that inflated prices for HIV medicines. A lawsuit filed four years ago accused Gilead of using a range of controversial business tactics that led the U.S. health care system to overspend for HIV medicines.
Giant kicks off 100th anniversary celebration with Make a Difference challenge
Drug Store News
JUNE 30, 2023
A multi-month celebration is rooted in connecting families for a better future and designed to thank team members, customers and communities, the company said.
Opinion: CMS must protect access to the ‘gold standard of breast reconstruction’
STAT
JUNE 30, 2023
In 1983, I flew home from college to be with my mother as she woke up from a mastectomy. She opted out of breast reconstruction, choosing to “go flat” instead. When I was diagnosed with breast cancer in 2017 and had bilateral mastectomies , I had more reconstruction options than my mother did.
Global PAT market expected to exceed $10b in 2032
European Pharmaceutical Review
JUNE 30, 2023
Demand for process analytical technology ( PAT ) is being driven by the growing adoption of automation and digitalisation in sectors such as pharmaceutical industry, a report by Market.us has found. With PAT being widely used in pharma, rising R&D expenses are anticipated to boost demand for these technologies. Growth and limitations in the global PAT market The PAT market is expected to grow $10.6 billion in 2032, the report suggested.
Let's personalize your content